MARKET NEWS

AbbVie has announced it will acquire Apogee Therapeutics
ProMed Pharma Announces Second Dedicated Manufacturing Suite Agreement at Niagara Lane Facility
Oryn Therapeutics Advances Next Phase of Orynotid Macrocyclic Peptide Platform Development with Expanded Leadership Team and Board Anchored by Accomplished Life Sciences Industry Veterans, Company Builders and Drug Developers

  FEATURED EDITORIAL

Drug Development & Delivery

  EXPERT INSIGHTS VIDEOS

Small Batches, Big Impact: The New Realities of CDMO Formulation Development

Small Batches, Big Impact: The New Realities of CDMO Formulation Development

  COMPANY PROFILE

Credence MedSystems is an award-winning innovator in drug delivery devices, solving emerging challenges in parenteral drug delivery for the pharmaceutical and biotechnology industry.

Credence’s philosophy of Innovation Without Change means that Credence technology is integrated with industry-standard syringe barrels, components and manufacturing processes, thereby providing highly innovative problem-solving products while minimizing the risk and burden of implementation for our pharma customers.

Click here for more.

  WHITEPAPERS & WEBINARS

WEBINAR ON DEMAND: Why early matters: Data-driven strategies to de-risk OSD development

WEBINAR ON DEMAND: Why early matters: Data-driven strategies to de-risk OSD development

Late-stage surprises continue to drive cost, delay, and challenges in oral solid dosage (OSD) development—especially for complex, poorly soluble molecules. Too often, formulation and manufacturability risks surface only after significant time and investment.

In a recent panel discussion, GlobalData’s Director …

WHITEPAPER - An Introduction to PLG Polymers for Long‑Acting Drug Delivery

WHITEPAPER - An Introduction to PLG Polymers for Long‑Acting Drug Delivery

Bioabsorbable poly(lactide-co‑glycolide) (PLG) polymers and poly(lactic acid-co-glycolic acid) (PLGA) have become an essential part of modern healthcare. Over the past five decades, these polymers have transformed how medicines are delivered – enabling long-acting injectables, implants, and localized drug‑delivery products …

WHITEPAPER - From Service Provider to Strategic Partner

WHITEPAPER - From Service Provider to Strategic Partner

By: Tom Sellig, CEO, Adare Pharma Solutions

As drug development grows more complex and timelines compress, sponsors require CDMO relationships built on integration, flexibility, and shared accountability. The relationship between pharmaceutical sponsors and their CDMO partners has undergone a fundamental …

WHITEPAPER - Stop Guessing. Start Predicting: Rethinking Early Oral Drug Development

WHITEPAPER - Stop Guessing. Start Predicting: Rethinking Early Oral Drug Development

Why Early Development Requires a Different Decision Model

Early oral drug development is an exercise in working under constraint. Teams are asked to make consequential decisions when materials are limited, timelines are tight, and the data are incomplete. Traditionally, formulation …

WHITEPAPER - Small Molecules: Choosing the Right Development Path

WHITEPAPER - Small Molecules: Choosing the Right Development Path

Summary

The white paper, Small Molecules: Choosing the Right Development Path, outlines a structured, risk-minimized approach to early CMC (Chemistry, Manufacturing, and Controls) development for small-molecule drugs—particularly for startups and virtual pharma companies with limited resources.

Key messages:

  • Start
…

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

July 8 – Analytical Testing
July 15 – ODT/Fast Dissolve
July 22 – Transdermal/Topical
July 29 – Drug Delivery